Hydrazino-type N.sub.2 S.sub.2 chelators
US5574140A · kind A · utility
7Cited by
18References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 1994 |
| Grant date | Nov 12, 1996 |
| Priority date | — |
| Expiry date | Jul 14, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.